BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29409947)

  • 1. De-escalating systemic therapy in triple negative breast cancer: The example of secretory carcinoma.
    Benabu JC; Stoll F; Koch A; Molière S; Bellocq JP; Mathelin C
    J Gynecol Obstet Hum Reprod; 2018 Apr; 47(4):163-165. PubMed ID: 29409947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma.
    Wong M; Jara-Lazaro AR; Hui Ng RC; Tiong Lim AS; Cheok PY; Lim TH; Tan PH; Wong NS
    Breast J; 2012; 18(6):604-6. PubMed ID: 23078524
    [No Abstract]   [Full Text] [Related]  

  • 3. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
    Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
    Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
    Chiosea SI; Griffith C; Assaad A; Seethala RR
    Am J Surg Pathol; 2012 Mar; 36(3):343-50. PubMed ID: 22301503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
    Vasudev P; Onuma K
    Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.
    Harrison BT; Fowler E; Krings G; Chen YY; Bean GR; Vincent-Salomon A; Fuhrmann L; Barnick SE; Chen B; Hosfield EM; Hornick JL; Schnitt SJ
    Am J Surg Pathol; 2019 Dec; 43(12):1693-1700. PubMed ID: 31498178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary analogue secretory carcinoma: the first submandibular case reported including findings on fine needle aspiration cytology.
    Petersson F; Lian D; Chau YP; Yan B
    Head Neck Pathol; 2012 Mar; 6(1):135-9. PubMed ID: 21773954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary Analog Secretory Carcinoma With ETV6 Rearrangement Arising in the Conjunctiva and Eyelid.
    Bao Y; Li J; Zhu Y
    Am J Dermatopathol; 2018 Jul; 40(7):531-535. PubMed ID: 29251639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma.
    Brown RJ; Murphy CD; Lisella GH; Libby AL; Njiaju UO; Rabinovitch RA; Borges VF
    Oncology (Williston Park); 2016 Jul; 30(7):628-31, 652. PubMed ID: 27432366
    [No Abstract]   [Full Text] [Related]  

  • 14. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.
    Reis-Filho JS; Natrajan R; Vatcheva R; Lambros MB; Marchió C; Mahler-Araújo B; Paish C; Hodi Z; Eusebi V; Ellis IO
    Histopathology; 2008 Jun; 52(7):840-6. PubMed ID: 18462362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
    Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
    Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6 gene rearrangements in invasive breast carcinoma.
    Letessier A; Ginestier C; Charafe-Jauffret E; Cervera N; Adélaïde J; Gelsi-Boyer V; Ahomadegbe JC; Benard J; Jacquemier J; Birnbaum D; Chaffanet M
    Genes Chromosomes Cancer; 2005 Sep; 44(1):103-8. PubMed ID: 15887243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
    Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
    Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.
    Ghilli M; Mariniello MD; Scatena C; Dosa L; Traficante G; Tamburini A; Caporalini C; Buccoliero AM; Facchini F; Colizzi L; Quattrini Li A; Landucci E; Manca G; Naccarato AG; Caramella D; Favre C; Roncella M
    Breast Cancer Res Treat; 2018 Aug; 170(3):445-454. PubMed ID: 29616377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
    Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
    Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.